Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-605,652
Closed -$32.6M 468
2023
Q2
$32.6M Buy
605,652
+75,741
+14% +$4.08M 0.13% 63
2023
Q1
$28.8M Buy
529,911
+29,161
+6% +$1.42M 0.11% 78
2022
Q4
$24.3M Buy
500,750
+478,062
+2,107% +$21M 0.09% 85
2022
Q3
$863K Buy
+22,688
New +$1.01M ﹤0.01% 550
2022
Q2
Sell
-180,477
Closed -$9.27M 739
2022
Q1
$9.27M Sell
180,477
-35,807
-17% -$1.85M 0.03% 161
2021
Q4
$10.8M Buy
216,284
+95,054
+78% +$4.7M 0.04% 119
2021
Q3
$5.84M Buy
121,230
+44,680
+58% +$2.27M 0.02% 196
2021
Q2
$4.03M Buy
+76,550
New +$3.99M 0.02% 247

Other funds holding SNY

Brookfield Corp's SNY Position: Q3 2023 in Review

Brookfield Corp sold out of Sanofi (SNY) in Q3 2023, closing a stake of 605,652 shares — an estimated $32.6M sold.

Brookfield Corp first reported a position in SNY in Q2 2021 and held it in 8 quarters. The position peaked at $32.6M in Q2 2023. 696 funds tracked by Wall St. Rank hold SNY as of Q3 2023.

  • Brookfield Corp reported no remaining Sanofi position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 605,652 Sanofi shares in Q3 2023, an estimated $32.6M.
  • Brookfield Corp first reported a position in Sanofi in Q2 2021 and held it in 8 quarters.
  • Brookfield Corp's Sanofi position peaked at $32.6M in Q2 2023.
  • 696 funds tracked by Wall St. Rank held Sanofi as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.